Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Zephyr Valve Japan Post-Marketing Surveillance

NCT: NCT06332885 · RECRUITING

NCT IDNCT06332885
StatusRECRUITING
Start Date2024-03-12
Completion2028-03-31
SponsorPulmonx Corporation (INDUSTRY)
First posted
Last updated

Brief Summary

This is a multicenter, prospective, observational surveillance enrolling 140 consecutive patients with severe emphysema who are candidates for bronchoscopic lung volume reduction using Zephyr Endobronchial Valve at up to 20 centers across Japan and followed for 12 months.

Frequently Asked Questions

What is Zephyr Valve Japan Post-Marketing Surveillance?

Zephyr Valve Japan Post-Marketing Surveillance is a clinical trial registered under NCT06332885. Current status: RECRUITING.

What is the status of NCT06332885?

The current status of NCT06332885 (Zephyr Valve Japan Post-Marketing Surveillance) is: RECRUITING.

When did Zephyr Valve Japan Post-Marketing Surveillance start?

Zephyr Valve Japan Post-Marketing Surveillance started on 2024-03-12.

Related Devices

K180011Pulmonx Chartis Tablet ConsolePulmonx Corporation K212494Lung Image AnalysisPulmonx Corporation K222340Chartis Precision CatheterPulmonx Corporation K253096Chartis Precision CatheterPulmonx Corporation PMA P180002Valve, pulmonaryPulmonx Corporation

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑